CLASS II Device recall · Reported 1 May 2019 · FDA Enforcement Report

St. Jude Medical Confirm Rx Insertable Cardiac Monitor recalled

Abbott is recalling St. Jude Medical Confirm Rx Insertable Cardiac Monitor, distributed nationwide in the US. The recall was initiated on 19 Nov 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial numbers 9225191, 9224501, 9225179, 9225193, 9225207, 9242209, 9257638, 9257646, 9257656, 9257659, 9224508, 9224490, 9224503, 9224525, 9224529, 9225190, 9225203, 9225205, 9225208, 9225211, 9225214, 9225851, 9225855, 9225858, 9225859, 9225867, 9225868, 9242199, 9242219, 9242225, 9242231, and 9256057.
Quantity recalled32 devices

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1220-2019
FDA event ID
82536
Recalling firm
Abbott, Sylmar, CA
Classification
Class II
Status
Terminated
Recall initiated
19 Nov 2018
FDA classified
25 Apr 2019
Reported
1 May 2019
Type
Voluntary: Firm initiated
Customers notified by
Visit
Reason category
Other Reasons
Device type
Patient Monitors

Timeline

19 Nov 2018Recall initiated by company
25 Apr 2019Classified by FDA+157 days
1 May 2019Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The device is unable to pair with the mobile app due to the device incorrectly determining the certificate has expired.

Product as listed by the FDA

St. Jude Medical Confirm Rx Insertable Cardiac Monitor, REF DM3500, Sterile. Product Usage: The St. Jude Medical Confirm Rx insertable cardiac monitor (ICM) is designed to detect arrhythmias and wirelessly transmit data to the Merlin.net Patient Care Network (PCN). It is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

Where it was distributed

US Nationwide Distribution in the states of AZ, CA, CO, ID, IL, LA, MA, MI, MO, NE, NH, NJ, NY, TN, TX, and WI.

Nationwide ArizonaCaliforniaColoradoIdahoIllinoisLouisianaMassachusettsMichiganMissouriNebraskaNew HampshireNew JerseyNew YorkTennesseeTexasWisconsin

Questions about this recall

Why was it recalled?

The device is unable to pair with the mobile app due to the device incorrectly determining the certificate has expired.

Which lots are affected?

Serial numbers 9225191, 9224501, 9225179, 9225193, 9225207, 9242209, 9257638, 9257646, 9257656, 9257659, 9224508, 9224490, 9224503, 9224525, 9224529, 9225190, 9225203, 9225205, 9225208, 9225211, 9225214, 9225851, 9225855, 9225858, 9225859, 9225867, 9225868, 9242199, 9242219, 9242225, 9242231, and 9256057.

Where was it sold?

US Nationwide Distribution in the states of AZ, CA, CO, ID, IL, LA, MA, MI, MO, NE, NH, NJ, NY, TN, TX, and WI.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Abbott

All 20

Other Patient Monitors recalls

All 1,022